External Evaluation

We have been selected for inclusion in the S&P/JPX Carbon Efficient Index, which was jointly developed by S&P Dow Jones Indexes, one of the world's largest independent index companies, and the Japan Exchange Group, and is based on the TOPIX (Tokyo Stock Exchange Stock Price Index) constituent stocks, focusing on environmental information disclosure status and carbon efficiency (carbon emissions per sales) levels. The index determines the weighting of constituent stocks by focusing on the level of environmental information disclosure and carbon efficiency (carbon emissions per sales volume) of the TOPIX (Tokyo Stock Exchange Stock Price Index) constituents. The index has been selected for management by the GPIF.

>Related links：S&P/JPX Carbon Efficient Index

We are included in the Morningstar Japan ex-REIT Gender Diversity Tilt The index focuses on companies that are committed to equal opportunities for employees regardless of gender. The index has been selected for management by the GPIF.

>Related links：Morningstar Japan ex-REIT Gender Diversity Tilt Index

It rates companies on a scale of 'AAA to CCC' based on the degree of ESG risk and how well they manage these risks compared to their peers.
We received a rating of A in 2022.

* THE USE BY EIKEN GROUP CORPORATION OF ANY MSCI ESG RESEARCH LLC OR ITS AFFILIATES (“MSCI”) DATA, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT, RECOMMENDATION, OR PROMOTION OF EIKEN GROUP CORPORATION BY MSCI. MSCI SERVICES AND DATA ARE THE PROPERTY OF MSCI OR ITS INFORMATION PROVIDERS, AND ARE PROVIDED ‘AS-IS’ AND WITHOUT WARRANTY. MSCI NAMES AND LOGOS ARE TRADEMARKS OR SERVICE MARKS OF MSCI.

The 'Resilience Certification' system was established by the Office of National Land Stewardship, Cabinet Secretariat, to certify businesses that support the government's land resilience objectives and are actively implementing initiatives related to business continuity as 'organisations contributing to national land resilience'.

We were certified in March 2019 under 'Business Continuity and Social Contribution'.

CDP is an international environmental non-profit organisation that scores and discloses information on responses from companies and others based on questionnaires on global environmental issues CDP scores are widely used in investment and procurement decision-making to build a net zero, sustainable and resilient economy.
We has been selected for the CDP's A List that is the highest rating available for climate change in 2024.

Synesgy is an ESG Global Digital Platform developed by CRIF Ratings, a credit rating agency licensed by ESMA (European Securities and Markets Authority). It complies with multiple sustainability standards and is recognized by the GRI. In Europe, it has become an important criterion for evaluating non-financial information such as investment, loan, and transaction decisions, and there are already about 500,000 companies that have been evaluated.
We have received an "A" rating, which is in the top 1% of all evaluated companies.

Eruboshi certification is granted by the Minister of Health, Labour and Welfare to companies that have formulated and submitted an action plan in accordance with the Law on the Promotion of Women's Advancement in Employment (commonly known as the Law for the Promotion of Women's Advancement), and whose status regarding the promotion of women's advancement is excellent. Companies are evaluated on the basis of five assessment criteria: recruitment, continued employment, working hours and other working methods, management ratio, and diverse career paths, and the number of criteria met determines the level of certification that can be obtained. In November 2023, we fulfilled the required criteria in all evaluation items and were awarded the highest accreditation of 3 stars.

Kurumin certification is awarded by the Minister of Health, Labour and Welfare to companies that provide excellent childcare support based on the Act on Advancement of Measures to Support Raising the Next Generation.
We have been certified as a 'Kurumin' company consecutively since 2016, and in October 2021 were certified as a 'Platinum Kurumin' company, which recognises companies that have already been certified as a 'Kurumin' company and are working to a higher standard.

We have been certificated as a 'Health Management Excellence Corporation 2023 (Large Corporations Sector)'  for the 4th consecutive year since 2020, under a joint sysytem to select and certify companies that are engaged in excellent health management by the Japan Health Council and METI.

In March 2023, We were awarded the 'Judging Committee's Special Prize' at the 13th 'The Most Valuable Company in Japan' Awards. The 'The Most Valuable Company in Japan' Awards is granted to companies that have made particularly excellent efforts in valuing people, including employees and their families, subcontractors and suppliers, customers, local communities and shareholders, who should really be valued by companies, and which have continuously implemented actions to realise human happiness, with the aim of setting a good example for other companies. The aim is to provide a model for other companies.

[Reasons for the award]
>The research and development-oriented company that manufactures and sells test-reagents and test-equipment, and can be regarded as a hidden excellent company that is steadily growing.
>The company produces COVID-19 detection kits and works hard as a whole to fulfil its responsibility to supply them.
>The company is also a good employer of  disabled persons (2.52%), and it is noteworthy that it has opened a farm within the company to provide them with a place to work.

The website of the 'Japan's Most Valuable Company' Award: https://www.htk-gakkai.org/a0013/MyHp/Pub/

In February 2023, the Eiken Group announced its endorsement of the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD).
In 2015 the Financial Stability Board (FSB), an international body based in Switzerland, established the TCFD. In its final report, tabled in June 2017, the TCFD recommended that companies disclose climate-related information that may affect their finances. The TCFD recommends disclosure of risks and opportunities presented by climate change in terms of four elements: governance, strategy, risk management, and indices and targets.

The Eiken Group recognizes the risk climate change poses for financial markets. In addition to reinforcing its current battery of measures to tackle climate change, the Group is advancing disclosure in accordance with the TCFD recommendations.

The Eiken Group participates in the TCFD Consortium.
The TCFD Consortium is an organization dedicated specifically to climate-related issues that assists companies in disclosing information based on TCFD recommendations.
Through its participation in the consortium, the Eiken Group will strengthen its company-wide efforts to disclose information based on TCFD recommendations and to create opportunities and measures to address risks.

Eiken Chemical has signed the Kigali Declaration, an international public-private partnership for the control of neglected tropical diseases (NTDs). The Declaration is a high-level declaration in which stakeholders pledge to work together for the elimination of NTDs. With the signing of the Declaration, we will further strengthen our collaboration with global partners to provide people affected by NTDs with access to rapid and accurate diagnosis and more effective treatment based on that diagnosis, and to promote efforts to achieve the World Health Organization (WHO) Roadmap 2021-2030 for the control of NTDs. We will continue to promote our efforts.

In December 2024, the Eiken Group joined Triple I for Global Health (Impact Investment Initiative for Global Health) , an initiative endorsed by G7 that aims to contribute to solving social issues in the field of global health through accelerating impact investments.
Our main product, the fecal occult blood test, is a screening test for colorectal cancer, contributing to the reduction of global colorectal cancer mortality and the reduction of overall medical costs. In addition, the infectious disease testing system using the LAMP method, a gene amplification technology developed by the company, is used in developing countries and medically depopulated areas where power infrastructure is not yet developed, contributing to the control of social losses caused by infectious diseases such as tuberculosis and malaria and economic development.
By participating in Triple I, we aim to contribute to solving social issues more than ever before.